Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
about
Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding siteAndrogen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanismArterial stiffness in diabetes and hypertension.The effect of antihypertensive drugs on endothelial function as assessed by flow-mediated vasodilation in hypertensive patients.Angiogenesis: a link to thrombosis in athero-thrombotic disease.Activated factor IX, factor XI and tissue factor identify patients with permanent atrial fibrillation treated with warfarin who are at risk of ischemic stroke.Elevated plasma migration inhibitory factor in hypertension-hyperlipidemia patients correlates with impaired endothelial function.The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in manAngiotensin II, tissue factor and the thrombotic paradox of hypertension.Protein anticoagulants targeting factor VIIa-tissue factor complex: a comprehensive review.Coronary angiogenesis during experimental hypertension: is it reversible?A prospective clinical study of flow-mediated dilatation in burn injury.Long-term treatment with ramipril favourably modifies the haemostatic response to acute submaximal exercise in hypertensives.Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].Increased sympathetic drive during the onset of hypertension in conscious Cyp1a1-Ren2 rats.Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
P2860
Q24627747-E7241CE8-828D-48E6-9E88-628387017E52Q34784556-40D62E75-0803-4125-900C-A878869F57D2Q35676290-9DEF6BB7-4191-432A-B2CE-3890F67E0425Q35830347-0319F90E-20CB-42EC-A6A2-FDC2A99AEC6BQ36030398-AC1CD7DF-C3B5-4A15-BAB7-F7D4B88F39B1Q37243007-611EDE87-BA28-479F-879B-DA8F4DD68E09Q37384162-E4FAB443-CDAA-4530-8941-59C556B155E8Q37479070-368548FC-DEBE-45F5-B0A7-E6C868773303Q37812379-D18B3124-4156-4FF9-BAB0-97057A372932Q38043676-4BC78D73-27C6-4143-A747-D53435D873F3Q39048348-025C84C9-A46B-460F-AC8F-45097A49318EQ41966560-8C45188E-05C8-4EA2-BAA2-A9AD023D428FQ43998698-74B87484-E6D6-4E02-94C8-EECC622B728EQ44956543-A1A0AE7D-77B8-4A1C-8B51-5E8A62C3498AQ45058820-0A1A3875-C5A3-49E2-807A-6DF8A7D8FF10Q46669142-B3CB8FDE-6E6F-4C2C-8834-884596D3E472Q46704786-BC87DC8D-8365-4D7F-809B-3712E3F9E2B1Q47695013-C547D11A-C5C5-4268-96E5-7CEACE009FAEQ50986493-CB2BA5B3-9B5D-493F-9B5E-045317F1AFE9
P2860
Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Relation of thrombogenesis in ...... rdiac Outcomes Trial [ASCOT]).
@en
type
label
Relation of thrombogenesis in ...... rdiac Outcomes Trial [ASCOT]).
@en
prefLabel
Relation of thrombogenesis in ...... rdiac Outcomes Trial [ASCOT]).
@en
P2093
P1476
Relation of thrombogenesis in ...... rdiac Outcomes Trial [ASCOT]).
@en
P2093
Andrew D Blann
Charles G C Spencer
D Gareth Beevers
Dirk C Felmeden
Funmi M Belgore
Natali A Y Chung
P304
P356
10.1016/S0002-9149(03)00657-X
P407
P577
2003-08-01T00:00:00Z